Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor (HR)-positive, HER2-positive metastatic breast cancer (ASPIRE).
Journal: Journal of the National Cancer Institute
Published: March 24, 2026
Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study.
Journal: Journal of cancer research and clinical oncology
Published: April 21, 2025
Inadequate Ovarian Function Suppression with GnRH Agonists and Subsequent Bilateral Salpingo-Oophorectomy Revealing Ovarian Stromal Hyperplasia in a Premenopausal Woman with Early-Stage, Hormone Receptor-Positive Breast Cancer: A Case Report.
Journal: Case reports in oncology
Published: March 10, 2025
Ultrasound-Guided Endometrial Aspiration and Immunohistochemistry for Detecting Focal Metastatic Cancer.
Journal: Journal of clinical ultrasound : JCU
Published: November 29, 2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
Journal: Journal of neuro-oncology
Published: February 27, 2024
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Journal: Neurosurgery
Published: April 20, 2023
Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach.
Journal: Current oncology (Toronto, Ont.)
Published: November 15, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
Journal: The oncologist
Published: July 26, 2021
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.
Journal: Breast (Edinburgh, Scotland)
Published: November 15, 2018
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: October 18, 2017
Last Updated: 09/26/2026